Ototoxicity monitoring in children treated with platinum chemotherapy

Beth Brooks, Kristin Knight

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To review the prevalence, mechanisms, clinical presentation, risk factors and implications of platinum-induced ototoxicity in paediatric cancer patients based on published evidence, discuss options for monitoring hearing in young children during treatment and review long-term follow-up guidelines. Design: Narrative literature review. Results: Children treated with cisplatin are at high risk of hearing loss and early, accurate identification of ototoxicity is important for medical decision making and hearing rehabilitation. Challenges of monitoring hearing in young children during cancer treatment and options for monitoring hearing are discussed. Conclusion: Hearing loss has important consequences for the survivors of childhood cancer including communication, learning, cognition and quality of life. Due to the presentation and configuration of ototoxic hearing loss, the test frequencies that are prioritised and the sequence of testing may differ from standard paediatric hearing evaluations. Hearing should be monitored during treatment and after completion of therapy.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalInternational Journal of Audiology
DOIs
StateAccepted/In press - Jul 21 2017

Fingerprint

Platinum
Hearing
cancer
monitoring
Drug Therapy
Hearing Loss
rehabilitation
cognition
quality of life
childhood
Hearing Tests
Pediatrics
decision making
narrative
Neoplasms
communication
Therapeutics
evaluation
Cognition
Cisplatin

ASJC Scopus subject areas

  • Language and Linguistics
  • Linguistics and Language
  • Speech and Hearing

Cite this

Ototoxicity monitoring in children treated with platinum chemotherapy. / Brooks, Beth; Knight, Kristin.

In: International Journal of Audiology, 21.07.2017, p. 1-7.

Research output: Contribution to journalArticle

@article{178dcf590875486abda99f5316b8457d,
title = "Ototoxicity monitoring in children treated with platinum chemotherapy",
abstract = "Objective: To review the prevalence, mechanisms, clinical presentation, risk factors and implications of platinum-induced ototoxicity in paediatric cancer patients based on published evidence, discuss options for monitoring hearing in young children during treatment and review long-term follow-up guidelines. Design: Narrative literature review. Results: Children treated with cisplatin are at high risk of hearing loss and early, accurate identification of ototoxicity is important for medical decision making and hearing rehabilitation. Challenges of monitoring hearing in young children during cancer treatment and options for monitoring hearing are discussed. Conclusion: Hearing loss has important consequences for the survivors of childhood cancer including communication, learning, cognition and quality of life. Due to the presentation and configuration of ototoxic hearing loss, the test frequencies that are prioritised and the sequence of testing may differ from standard paediatric hearing evaluations. Hearing should be monitored during treatment and after completion of therapy.",
author = "Beth Brooks and Kristin Knight",
year = "2017",
month = "7",
day = "21",
doi = "10.1080/14992027.2017.1355570",
language = "English (US)",
pages = "1--7",
journal = "International Journal of Audiology",
issn = "1499-2027",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Ototoxicity monitoring in children treated with platinum chemotherapy

AU - Brooks, Beth

AU - Knight, Kristin

PY - 2017/7/21

Y1 - 2017/7/21

N2 - Objective: To review the prevalence, mechanisms, clinical presentation, risk factors and implications of platinum-induced ototoxicity in paediatric cancer patients based on published evidence, discuss options for monitoring hearing in young children during treatment and review long-term follow-up guidelines. Design: Narrative literature review. Results: Children treated with cisplatin are at high risk of hearing loss and early, accurate identification of ototoxicity is important for medical decision making and hearing rehabilitation. Challenges of monitoring hearing in young children during cancer treatment and options for monitoring hearing are discussed. Conclusion: Hearing loss has important consequences for the survivors of childhood cancer including communication, learning, cognition and quality of life. Due to the presentation and configuration of ototoxic hearing loss, the test frequencies that are prioritised and the sequence of testing may differ from standard paediatric hearing evaluations. Hearing should be monitored during treatment and after completion of therapy.

AB - Objective: To review the prevalence, mechanisms, clinical presentation, risk factors and implications of platinum-induced ototoxicity in paediatric cancer patients based on published evidence, discuss options for monitoring hearing in young children during treatment and review long-term follow-up guidelines. Design: Narrative literature review. Results: Children treated with cisplatin are at high risk of hearing loss and early, accurate identification of ototoxicity is important for medical decision making and hearing rehabilitation. Challenges of monitoring hearing in young children during cancer treatment and options for monitoring hearing are discussed. Conclusion: Hearing loss has important consequences for the survivors of childhood cancer including communication, learning, cognition and quality of life. Due to the presentation and configuration of ototoxic hearing loss, the test frequencies that are prioritised and the sequence of testing may differ from standard paediatric hearing evaluations. Hearing should be monitored during treatment and after completion of therapy.

UR - http://www.scopus.com/inward/record.url?scp=85025672196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025672196&partnerID=8YFLogxK

U2 - 10.1080/14992027.2017.1355570

DO - 10.1080/14992027.2017.1355570

M3 - Article

C2 - 28737048

AN - SCOPUS:85025672196

SP - 1

EP - 7

JO - International Journal of Audiology

JF - International Journal of Audiology

SN - 1499-2027

ER -